3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Motor Activity
9
Neoplasms
4
Breast Neoplasms
3
Weight Loss
2
Ventricular Dysfunction, Left
1
Urinary Incontinence
1
Sexual Dysfunction, Physiological
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Melanoma
1
Lymphoma
1
Leukemia
1
Insulin Resistance
1
Hypoxia
1
Hematologic Neoplasms
1
Heart Failure
1
Head and Neck Neoplasms
1
Fecal Incontinence
1
Fatigue
1
Cardiotoxicity
1
Carcinoma, Renal Cell
1
Cachexia
1
Brenner Tumor
1
Breast Diseases
1
Brain Neoplasms
1
Bone Metastases
1
Body Weight
1
Interventions
Injections
2
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
2
alovudine
1
Nitroglycerin
1
Magnetic Resonance Spectroscopy
1
Exercise
1
Drug Therapy
1
Bacterial Load
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Hypoxia
×
Exercise
×
Clear all
NCT03365076
2023-01-09
EXIPOX
University Hospital of North Norway
Phase NA
Terminated
1 enrolled